Clearstead Trust’s Axcelis ACLS Stock Holding History

Clearstead Trust’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9	Closed	-$879	–	1008
2025 Q3	$879	Hold	9	–	–	﹤0.01%	1249
2025 Q2	$628	Buy	+9	New	+$513	﹤0.01%	1284

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Clearstead Trust's ACLS Position: Q4 2025 in Review

Clearstead Trust sold out of Axcelis (ACLS) in Q4 2025, closing a stake of 9 shares — an estimated $879 sold.

Clearstead Trust first reported a position in ACLS in Q2 2025 and held it in 2 quarters. The position peaked at $879 in Q3 2025. 370 funds tracked by Wall St. Rank hold ACLS as of Q4 2025.

Clearstead Trust reported no remaining Axcelis position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 9 Axcelis shares in Q4 2025, an estimated $879.
Clearstead Trust first reported a position in Axcelis in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Axcelis position peaked at $879 in Q3 2025.
370 funds tracked by Wall St. Rank held Axcelis as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.